Showing 478 news articles about New & experimental hepatitis C treatment

Filters Content type: Editors' picks Topic: New & experimental hepatitis C treatment

News and information about clinical trials and regulatory approval of new medications to treat hepatitis C.

New & experimental hepatitis C treatment

Medgenics' Bulging Pipeline Of Blockbuster Indications Takes On Big Pharma's Harmful Drugs

Editor's pick
Seeking Alpha
19 September 2012
New & experimental hepatitis C treatment

Casualties of an R&D war? Hep C trial patients accuse Bristol-Myers

Editor's pick
Fierce Biotech
18 September 2012
New & experimental hepatitis C treatment

Achillion Deal Looming as Hepatitis Drugs Fail: Real M&A

Editor's pick
Business Week
30 August 2012
New & experimental hepatitis C treatment

Bristol-Myers Squibb Discontinues Development of BMS-986094, an Investigational NS5B Nucleotide for the Treatment of Hepatitis C

Editor's pick
Bristol Myers Squibb press release
24 August 2012
New & experimental hepatitis C treatment

Australia: New drugs offer hope to hepatitis C sufferers

Editor's pick
Sydney Morning Herald
24 August 2012
Hepatitis C treatment

Vitamin B12 During Hepatitis C Treatment

Editor's pick
Hepatitis Central
22 August 2012
New & experimental hepatitis C treatment

Drug Successfully Halts Fibrosis in Animal Model of Liver Disease

Editor's pick
Science Daily
8 August 2012
New & experimental hepatitis C treatment

Achillon hep C drug shows promise in mid-stage study

Editor's pick
Reuters
8 August 2012
New & experimental hepatitis C treatment

Like Gilead, Achillion Should Trade Up On Bad News For Bristol-Myers, Idenix

Editor's pick
Reuters
2 August 2012
New & experimental hepatitis C treatment

Bristol-Myers Suspends Hepatitis C Drug Clinical Trial - Bloomberg

Editor's pick
Google Alerts - Hepatitis
2 August 2012
New & experimental hepatitis C treatment

Gilead Begins Single Pill Hepatitis C Study for 2014 Approval

Editor's pick
Businessweek
29 July 2012
New & experimental HIV treatments

TAG/i-base 2012 Pipeline Report - HIV/HCV/TB

Editor's pick
Treatment Action Group
21 July 2012
New & experimental hepatitis C treatment

Vitamin B12 supplements may help treat hepatitis C

Editor's pick
Eurekalert
18 July 2012
New & experimental hepatitis C treatment

Medivir announces an interferon-free phase II combination trial of hepatitis C drugs TMC435 and daclatasvir to commence shortly

Editor's pick
Medivir
29 June 2012
New & experimental hepatitis C treatment

EASL-AASLD Special Conference on Therapy of Hepatitis C

Editor's pick
Eurekalert Inf Dis
28 June 2012
New & experimental hepatitis C treatment

Bristol Hep C Trial Change Has Big Implications

Editor's pick
Pharmalot
21 June 2012
New & experimental hepatitis C treatment

Idenix hep C drug shows promise in mid-stage study

Editor's pick
Reuters
20 June 2012
Pharmaceutical industry

Vertex Goes From Bad Data To A Bad Promotion

Editor's pick
Pharmalot
1 June 2012
New & experimental hepatitis C treatment

Bristol urges combo study with Gilead hepatitis drug

Editor's pick
Reuters
31 May 2012
New & experimental hepatitis C treatment

Hepatitis C 'switch' offers target for new drug research

Editor's pick
Science Codex
31 May 2012
Hepatitis C treatment

FDA says Vertex promotional material overstates benefits of hepatitis C drug

Editor's pick
Boston Globe
31 May 2012
New & experimental hepatitis C treatment

GSK seeks to expand low-platelet drug Promacta to hepatitis C patients

Editor's pick
MedCity News
31 May 2012
Hepatitis C treatment

HCV patients may be able to delay therapy

Editor's pick
MedPage Today
23 May 2012
Pharmaceutical industry

How CDC's hep.-C testing advice is already benefiting drugmakers

Editor's pick
Medical Marketing and Media
23 May 2012